Listen to this article

Anyone who was ever experienced difficulty swallowing medication or who has struggled to help a child or pet take their prescriptions will welcome the work of Bryan Ridall, Vincent Mileto and their team at Orcosa.

The Ewing-based company developed the The RITe Platform. The technology produces an easy-to-take orally disintegrating tablet that rapidly infuses an active ingredient through the tissue in the cheek – enabling therapeutic effects quickly and efficiently. The medication dissolves in seconds, without swallowing, avoiding the problems that can plague human and animal patients with certain conditions.

If the product becomes widely used, pet owners will no longer have to hide pills in peanut butter or cheese to get their furry friends to take their medications.

The company has received positive test results from its Oravexx pain treatment. The non-addictive proprietary cannabidiol compound is currently being studied in clinical trials. The company recently participated in BioNJ’s BioPartnering Conference in Jersey City.

In this edition of NJBIZ Conversations, Ridall and Mileto discuss Ocrosa’s origins, the promise of its technology and where the life sciences company will head next.

Watch the interview below:

To listen instead, click on the podcast: